Docosahexaenoic acid protects against palmitate-induced mitochondrial dysfunction in diabetic cardiomyopathy - 18/06/20
, Zhibo Gai a, b, c, ⁎ Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
| pages | 8 |
| Iconographies | 6 |
| Vidéos | 0 |
| Autres | 0 |
Graphical abstract |
Highlights |
• | DHA alleviated PA-induced cytotoxicity in cardiomyoblast cells. |
• | DHA ameliorated the progression of cardiomyopathy in a HFD-fed rat model of diabetes. |
• | DHA improved palmitate-induced mitochondrial dysfunction both in vivo and in vitro. |
Abstract |
Objective |
Regular consumption of n-3 polyunsaturated fatty acids is associated with decreased cardiovascular morbidity and mortality. This study assessed the therapeutic effect of docosahexaenoic acid (DHA) in palmitic acid (PA)-induced cytotoxicity in vitro and in rats fed a high-fat diet (HFD).
Methods |
H9C2 cells and rat primary cardiomyoblasts were exposed to PA or PA + DHA for 24 h. PA-induced lipotoxicity and mitochondrial dysfunction were evaluated by immunostaining, real-time PCR, cardiomyocyte contraction and transmission electron microscopy. The effects of dietary DHA on diabetic cardiomyopathy were evaluated in male Sprague-Dawley rats fed a reference diet rich in DHA, an HFD, or an HFD with added DHA for 16 weeks. Oxidative stress and lipotoxicity in rat heart tissue were assayed by Masson staining, immunohistochemistry, and TUNEL.
Results |
In vitro studies showed that dietary DHA reduced the occurrence of cardiomyopathy and improved cardiac responses to PA. In the rat model, dietary DHA reduced mitochondrial oxidative stress in HFD-induced diabetic cardiomyopathy.
Conclusion |
Dietary DHA reduced mitochondrial oxidative stress and ameliorated PA-induced lipid toxicity. DHA consumption may have had direct effects on cardiovascular risk via myocardial protection.
Le texte complet de cet article est disponible en PDF.Abbreviations : AOX, Col 1, CPT1, DCM, DHA, EPA, GLUT4, HFD, PA, PPAR, PUFAs, PDK-4, TG, TGFβ, ROS
Keywords : Docosahexaenoic acid, Palmitic acid, Cardiac lipotoxicity, Mitochondrial function, Diabetic cardiomyopathy
Plan
Vol 128
Article 110306- août 2020 Retour au numéro
Article précédent
- The novel camptothecin derivative, CPT211, induces cell cycle arrest and apoptosis in models of human breast cancer
- Ching-Feng Chiu, Yu-Qiang Lin, Ji Min Park, Yung-Chia Chen, Shao-Wen Hung, Chien-Chao Chiu, Chi-Fen Chang
- Analysis of the molecular mechanism of Pudilan (PDL) treatment for COVID-19 by network pharmacology tools
- Qi Kong, Yue Wu, Yu Gu, Qi Lv, Feifei Qi, Shuran Gong, Xiuping Chen
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’achat d’article à l’unité est indisponible à l’heure actuelle.
Déjà abonné à cette revue ?